Fundraising FoxDe Novo Ventures — Full Portfolio
9 tracked investments · listed companies and verified rows first
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform.
BiotechFemTechHealthtechPrinceton, US
Katie MacFarlane(Executive Officer)inScott M. Coiante(Executive Officer)Al Altomari(Executive Officer, Director)inElizabeth Garner(Executive Officer)in
BoardKaren Hong(Director)inAbhijeet Lele(Director)
Co-investorsAisling CapitalKaiser Permanente Ventures
Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.
BiotechHealthtechCambridge, US
Kevin Mills(Executive Officer, Director)inRonald Goldstein(Executive Officer)inDonald Corcoran(Executive Officer, Director)inMarkus Renschler(Director)in
BoardTimothy Romberger(Director)Barry Mills(Director)
Co-investorsDroia VenturesLightstone VenturesOUP (Osage University Partners)Shah Family OfficeAlly Bridge GroupJanus Henderson Investors+4 more
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in
BoardMichael Carusi(Director)inArda Minocherhomjee(Director)
Co-investorsAccelmed PartnersCanaan PartnersEvidity Health CapitalLightstone VenturesVCFA GroupAdvanced Technology Ventures+2 more
Milo is an AI assistant that helps parents manage daily family tasks through text message conversations, combining large language models with human oversight to handle logistical and organizational work.
AI & Machine LearningConsumerSan Francisco, US
Avni Patel Thompson(Founder)in
Co-investorsBronze InvestmentsM13Y CombinatorAlteria CapitalAntlerBessemer Venture Partners+4 more
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages.
BiotechMedical DevicesNew York, US
Dr. Bing Yuan(Co-Founder, Chief Executive Officer)Dr. Eric Slosberg(Co-Founder, Chief Development Officer)Dr. Andy Fu(Co-Founder, Chief Business Officer)Bing Yuan, Ph.D., MBA(Co-Founder, Chief Executive Officer)Eric Slosberg, Ph.D.(Co-Founder, Chief Development Officer)Andy Fu, PharmD, MBA(Co-Founder, Chief Business Officer)
Co-investorsOrbiMedCatalio Capital Management, LPF-Prime CapitalSofinnova VenturesInsight PartnersNVIDIA
StrideBio develops gene therapies based on its STRIVE AAV capsid platform, targeting people with life-threatening diseases.
BiotechHealthtechDurham, US
Aravind Asokan(Director)inMavis Abjandje-McKenna(Director)Richard Smith(Executive Officer)inPatrick Ritschel(Executive Officer, Director, Promoter)
Co-investorsPontifax Venture CapitalAbingworthHatteras Venture PartnersNorthpond Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.